Central administration of neurokinin B (NKB) agonists stimulates immediate early gene expression in the hypothalamus and increases secretion of vasopressin from the posterior pituitary through a mechanism that depends on the activation of neurokinin receptor 3 receptors (NK3R). Here we report that, in the rat, immunoreactivity for NK3R is expressed in magnocellular vasopressin and oxytocin neurones in the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus, and that NKB immunoreactivity is expressed in fibres in close juxtaposition with vasopressin neurones at both of these sites.
Introduction
The peptide hormone vasopressin is synthesised in magnocellular neurosecretory neurones in the supraoptic (SON) and paraventricular (PVN) nuclei of the hypothalamus, and is the main hormonal regulator of plasma osmolality and body water content. In the elderly, about half of all cases of chronic hyponatremia are attributed to chronically elevated secretion of vasopressin (1) . In humans, vasopressin secretion progressively increases with age (2, 3) , and the size of magnocellular vasopressin neurons in the SON and PVN is increased after the age of 60 years, suggesting that there is also an increase in vasopressin production (2, 4) . In aged rodents, there is also an increase in vasopressin secretion, and this has been linked to impaired osmoregulation (5) . Aging is also associated with a marked decline in sex steroid production in both men and women, but whether the age-related increase in vasopressin synthesis and secretion is linked to age-related decline in sex steroid production is not known.
In this study, we explored neuroanatomical and functional interactions between neurons that express neurokinin B (NKB) and magnocellular vasopressin neurons. NKB, a member of the tachykinin neuropeptide family, is a critical regulator for the central control of reproduction. The biological effects of tachykinins are mediated by three different neurokinin receptors: NK1R, NK2R, NK3R, and NKB preferentially binds to NK3R (6) . The earliest evidence of a role for NKB in human reproduction came from a study of postmenopausal women by Rance and Young (7) which demonstrated hypertrophy and hyperplasia of cells containing NKB in the infundibular nucleus -the nucleus homologous to the arcuate nucleus in rodents. Similar results have since been found in the infundibular nucleus of the aging man (8) . This led to the recognition that NKB expression is inversely correlated to levels of circulating sex steroids. Thus, for example, NKB expression is greatly elevated by gonadectomy in a manner reversible by replacement with sex steroids (9) . A similar pattern has been described in monkeys, where ovariectomy results in neuronal hypertrophy and an increase of NKB mRNA expression (10) . In addition, gonadal steroids have been reported to have marked effects on the somata and dendrites of arcuate nucleus NKB neurons (11) .
There is already considerable evidence that the NKB/NK3R system may regulate vasopressin secretion. Central injection of a selective NK3R agonist, senktide, induces antidiuresis by increasing peripheral vasopressin secretion (12) , whereas neurokinin A, substance P and selective NK-1 agonists have no such effect. The actions of senktide are likely to be direct, as mRNA for NK3R is expressed in both the SON and PVN (13) , and as senktide can also stimulate vasopressin secretion from explants of the hypothalamohypophysial system (14) . Conversely, central administration of a NK3R antagonist reduces osmotically-stimulated vasopressin secretion in rats (15) .
In this study, using immunocytological and electrophysiological approaches, we aimed to determine 1) whether there is an anatomical connection between the NKBproducing neurones in the arcuate nucleus and vasopressin neurones in the SON and PVN, and 2) the effects of the NK3R agonist, senktide, on the electrical activity of magnocellular vasopressin and oxytocin neurones in the SON.
Materials and Methods
Experiments were performed on adult male Sprague-Dawley rats (body weight ~ 300 g) and adult male transgenic Kiss1/Cre-eGFP mice (body weight ~ 30 g) that had been housed on a 12:12 h light:dark cycle (lights off at 19.00 h) with free access to food and water.
All experiments were conducted in accordance with a UK Home Office project licence that has been reviewed by the University of Edinburgh Ethics Committee.
Tracing/Connectivity studies
For retrograde tracing experiments, we used retro-beads as they show very limited spread from the injection site, and do not need an antibody for detection (16) . The injection method we used is described in detail elsewhere (17) . Rats were anesthetized first with 4% isoflurane and then maintained on 1.5 -2% isoflurane. They were placed in a stereotaxic frame and a glass capillary was implanted in SON using the following coordinates (18):
anterioposterior -1.3 mm; mediolateral 2.0 mm; dorsoventral 9.4 mm. Red retro-beads (Lumafluor, Inc.) were injected in the SON (100 nl) by pressure injection. Once the wound was sutured, rats were given buprenorphine (0.03 mg/kg) subcutaneously. One week after injection, the rats were transcardially perfused, and the brains were removed and processed for immunofluorescence as described below.
Anterograde tracing
Recombinant adeno-associated virus vectors (rAAVs) have been commonly used to deliver genes of interest into the central nervous system in vivo. Here we used a credependent approach to deliver YFP specifically to arcuate nucleus kisspeptin neurons (19, 20) . Kisspeptin-expressing neurons in the arcuate nucleus of rodents (21, 22) , sheep (23) , and monkey (24) co-express NKB and dynorphin. Using this property of arcuate kisspeptin neurons, we used the transgenic Kiss1/Cre-eGFP knock-in mouse (25) to trace kisspeptin arcuate nucleus projections to the SON and PVN.
We used an AAV where an inverted YFP reporter sequence was floxed by two LoxP sequences oppositely oriented. Thus, after the cre-recombinant event in kisspeptin cells, YFP was orientated to the correct sense and transduced specifically in cre cells only under the constitutively-expressed elongation factor 1-alpha promoter (Ef1a) (26, 27) . This type of AAV, commonly known as a DIO-AAV, was purchased from Gene Therapy Center Vector Core (University of North Carolina; serotype 5; viral titer 10 12 vg/ml). Using a similar approach to that described in the retrograde tracing study above, Kiss1/Cre-eGFP mice were injected with 300 nl of the DIO-AAV into the arcuate nucleus following the coordinates (28):
anterioposterior -1.8 mm; mediolateral 0.3 mm; dorsoventral 5.8 mm. Although this transgenic line expresses eGFP under the kisspeptin promoter, this expression is restricted to the nucleus, thus, any YFP projections found come from the AAV-DIO-YFP. Three weeks after injection, mice were perfused transcardially with paraformaldehyde, and the brains were removed and processed for double immunofluorescence as described below.
Immunofluorescence protocols
Adult male rats (body weight ~300 g) and adult male Kiss1/Cre-eGFP mice were injected with a lethal dose of sodium pentobarbitone and transcardially perfused with heparinised 0.9% saline, followed by 4% paraformaldehyde in 0.1 M phosphate-buffered saline (pH 7.3-7.4). Brains were extracted and post-fixed overnight at 4ºC in 2% PFA + 15% sucrose solution then cryoprotected in 30% sucrose in PBS with 0.01% sodium azide.
Coronal brain sections (40 μm) were cut on a freezing microtome.
For NK3R and NKB immunoreactivity studies, sections were mounted on SuperFrost
Plus slides then dried for 1 h at 37ºC. Sections were washed in PBS-T (0.1% Tween-20) for 10 min at room temperature. Heat-induced epitope retrieval (HIER) was then performed in 10 mM sodium citrate pH 6 for 10 min at 90ºC. Afterwards, sections were cooled to room temperature and then washed for 5 min in PBS at room temperature. The sections were incubated in blocking buffer (3% donkey or goat serum, 0.4% Triton X-100 in PBS) for 45 min at room temperature. Next, the sections were incubated with primary antibodies (Table   1) in blocking buffer for two days at 4ºC, then washed three times for 10 min in PBS. Finally, the sections were incubated with secondary antibodies (Table 1) in blocking buffer for 1 h at 37ºC, then washed three times for 10 min in PBS, and mounted on slides using PermaFluor Aqueous Mounting Medium (Thermo Scientific, TA-030-FM). No signal was detected after applying secondary antibodies in the absence of primary antibodies.
For the anterograde tracing study using AAV, we used the same protocol as described above but without the HIER step. The anterograde tracing study did not allow us to use simultaneously visualize NKB by immunohistochemistry. While the specificity of the NKB antibody is high, its sensitivity is low, and we were able to label fibres only after the HIER step, which compromises the detection of YFP. (Table 1 ) diluted in blocking buffer for 2 days at 4ºC. After incubation with the primary antibody, sections were washed four times for 10 min in 0.1 M PB, followed by a 2 h incubation with secondary antirabbit antibody Alexa 488 (Table 1) . Finally, sections were mounted in SuperFrost Plus slides using Fluoromount (Sigma -F4680) after washing. All incubations were at room temperature unless stated.
Immunoreactivity was visualized on the Nikon A1R FLIM confocal system. Images were viewed and Z stacks condensed to maximum intensity projections using NIS-Elements
Viewer software. Resulting images were exported to the ImageJ software. To facilitate colorblind readers, the red channel was recolored to magenta; overlay of green and magenta channels results in a white colour channel. 
In vivo electrophysiology
Adult male rats were anesthetized with urethane (1.25 g/kg, i.p.), a femoral vein was cannulated and a catheter was inserted in the trachea. The SON and an area rostral to the pituitary and on the midline were exposed transpharyngeally, as described fully elsewhere (29) . A microinjection cannula was placed 0.5-1 mm rostral to the neural stalk and on the midline then lowered into the third ventricle to inject 600 pmol of senktide in a volume of 2 µl over 100 s. Under visual control, a glass microelectrode (tip diameter ~ 1 µm) filled with 0.9% NaCl was placed in the SON to record from single neurones using conventional extracellular recording techniques.
In this study, unlike our previous electrophysiological studies on SON neurones, we could not identify these neurones antidromically as projecting to the posterior pituitary gland because inserting a microinjection cannula ventrally into the 3rd ventricle did not leave enough space to also place a stimulating electrode on the neural stalk and a recording electrode in the SON. We therefore used other ways to ensure that we recorded from 
Results

NK3R and NKB immunoreactivity in the SON and PVN.
In the SON and PVN (Fig 1,2) , we found dense expression of NK3R immunoreactivity whereas the surrounding perinuclear zones were apparently devoid of NK3R immunoreactivity, indicating a strong and specific expression of NK3R in magnocellular neurones. Within the SON and PVN, the immunoreactivity was mainly absent from cell nuclei, and apparently mainly (but not exclusively) localised to the neuronal cell membranes (Fig 1D, 2D) . In both nuclei, NK3R expression was co-localized with both vasopressin-neurophysin ( Fig. 1 ) and oxytocin-neurophysin (Fig. 2) . NK3R expression was also found in all the accessory magnocellular nuclei including in the nucleus circularis, and in the retrochiasmatic part of the SON (images not shown). In the SON, NK3R was expressed in all neurones, but in the PVN it was preferentially expressed in vasopressin cells (Fig 1C, Fig.   2C ). To quantify this, we analysed sections of the PVN from three rats, sampling cells that expressed vasopressin-neurophysin or oxytocin-neurophysin, and which could be unambiguously defined as NK3R-positive or NK3R-negative. Of 111 vasopressin cells, 99 co-expressed NK3R (89%), whereas of 128 oxytocin cells, only 36 (28%) co-expressed NK3R.
Consistent with previous studies, we observed a large population of NKB-expressing cells in the caudal arcuate nucleus (not shown). NKB-positive fibers from these cells passed through the rostral arcuate nucleus, and some of these could be seen to enter the caudal region of the SON (Fig. 3A) ; other fibres coursed dorsally towards the PVN alongside the walls of the third ventricle ( Fig 3A) . Within both the SON and PVN, we found abundant expression of NKB-expressing fibres with boutons in close juxtaposition to vasopressin cells (Fig. 3B,C) . However, we did not find any NKB-expressing cell bodies in either of these nuclei.
Projections of NKB-expressing cells from the arcuate nucleus
Retrograde study These immunohistochemical studies suggested that at least some of the NKB projections found within the SON originated from NKB-expressing cells in the caudal arcuate nucleus. To test this, we aimed to inject retro-beads into one SON side in six rats, and present here the results from two rats in which the injection was on target with minimal spread outside the SON (Fig. 4A ). We used a small volume of retro-beads to achieve higher specificity, so we expected to inject only a small area of the SON and therefore only a few fibres were likely to uptake the beads. A week after injection, retro-beads injected into the SON were found in the cytoplasm of 11% of NKB-expressing cells (27 out of 238 cells) in the caudal arcuate nucleus (Fig. 4B-F) .
Anterograde study We injected a cre-dependent AAV-DIO-YFP in the arcuate nucleus of three kiss1-Cre/eGFP mice, and present here the results from two mice in which the injection was on target (Fig. 5A) . We found YFP-expressing fibers in the PVN and SON (Fig. 5B,C) , indicating that some kisspeptin-expressing cells in the arcuate nucleus project to both these nuclei in mice. 
Effect of NKB on the electrical activity of SON vasopressin and oxytocin neurones
In the SON of urethane-anaesthetised rats we recorded from 17 vasopressin neurones (mean basal rate 5.1 ± 0.76 spikes/s), of which 10 were firing phasically and seven were firing continuously. Those firing continuously were identified as vasopressin neurones by their response to CCK (inhibition or no response) and by analysing the nature of their firing pattern: hazard functions constructed from interspike interval data revealed the presence of a post-spike hyperexcitability that is uniformly present in vasopressin neurones (30) but mainly absent from oxytocin neurones (Fig. 6B) .
Of the 17 neurones, one phasic neurone was lost at 10 min after senktide injection, after increasing its firing rate from 8.0 to 9.7 spikes/s in that time. The other 16 neurones were all kept for between 30 and 60 min after injection, and the mean firing rate of these, averaged over 20-40 min after injection, was 2.1 ± 0.7 spikes/s higher than the basal rate ( Fig. 6A and C; P = 0.008, Mann-Whitney test).
The nine phasically firing neurones that were held for more than 30 min had a mean basal rate 3.3 ± 0.7 spikes/s (range 0.5 -8 spikes/s); this activity comprised bursts and intervening silences, and to assess whether the response to senktide was due to a change in the burst length or/and a change in burst intensity we analysed the changes in the activity quotient (AQ = time active / time recorded) and in the intraburst frequency. The AQ was raised by 0.19 ± 0.11 from 0.49 ± 0.07 to 0.68 ± 0.1 at 20-40 min after senktide injection (Fig. 6E) , and intraburst frequency was increased by 1.1 ± 0.6 spikes/s from 6.2 ± 0.5 spikes/s to 7.3 ± 0.7 spikes/s (Fig. 6F ).
The seven continuously firing vasopressin neurones had a mean basal firing rate of 7.5 ± 1.7 spikes/s (range 1.9 -10.7 spikes/s). Between 20 and 40 min after senktide injection, the mean firing rate was 1.7 ± 0.7 spikes/s higher than basal; in one of these neurones the firing rate was lower (by 0.9 spikes/s), but in five of the neurones it was increased by at least 1.5 spikes/s.
We also recorded from seven putative oxytocin neurones (mean basal rate 5.25 ± 0.8 spikes/s; range 2.6 -6.9 spikes/s), all of which were recorded in close proximity to identified vasopressin neurones, and which were identified either by their excitatory response to i.v.
CCK or by the shape of their interspike-interval histograms and resulting hazard functions (30) . Overall, senktide had no significant effect on the electrical activity of these neurones
(mean change at 20-40 min after senktide, -0.2 ± 0.7 spikes/s; Fig. 6C ). 
Discussion
Here, we confirmed that, in the rat, as previously reported (31), neurokinin receptor NK3R is densely expressed in vasopressin and oxytocin cells in the SON and PVN. We also confirmed that, in the PVN, NK3R is expressed by most vasopressin cells but by only some oxytocin cells (32) ; but in the SON it appeared that all neurones, including all oxytocin cells, express NK3R. NKB was expressed in fibres in close juxtaposition with vasopressin cells in both the SON and PVN. However, we failed to find NKB expression in cell bodies in either the SON or the PVN, in accord with in situ hybridisation studies which failed to detect NKB mRNA expression in these nuclei (33) (34) (35) , but in contradiction to a previous study which reported co-immunostaining of NKB and vasopressin in SON and PVN neurones (36) . We also showed that some NKB-expressing cells in the rat arcuate nucleus project to the SON, and in mice, we found by anterograde tracing that arcuate kisspeptin-expressing cells, which are known to co-express NKB, project to both the SON and PVN. In neurones of the arcuate nucleus, NKB is co-localised with kisspeptin and dynorphin, so projections of this pathway to oxytocin and vasopressin neurones may have different actions depending on which receptors are present postsynaptically, and possibly also depending on differential targeting of peptides to secretory vesicles at different sites.
Dynorphin is likely to be inhibitory to both oxytocin and vasopressin neurones in the SON via its actions at kappa-opioid receptors that are expressed on both of these neuronal types Vasopressin regulates water uptake in the distal renal tubules and elevated levels can result in hyponatremia. In the elderly, hyponatremia, the most common electrolyte disorder, can be a serious health burden: common complications include an increased incidence of falls resulting from mental confusion, and osteoporosis, together giving an increased risk of fractures. About half of all cases of chronic hyponatremia are attributed to chronically elevated secretion of vasopressin (1, 2): in humans, vasopressin secretion progressively increases with age (3, 5) , and the size of magnocellular vasopressin neurones in the SON and PVN is increased after the age of 60 years, suggesting that there is also an increase in vasopressin production (2) . In aged rodents, there is also an increase in vasopressin secretion, and this has been linked to impaired osmoregulation (54) .
Aging is also associated with a marked decline in sex steroid production in both men and women. This decline leads to an increase in the expression of NKB in the hypothalamus of humans and rodents alike, and may contribute to the progressive rise in vasopressin secretion that accompanies aging (2) . In aging, chronic hyponatremia resulting from inappropriately increased vasopressin secretion has been causally linked to osteoporosis, as has reduced gonadal steroid secretion. Osteoporosis has an incidence peak in advanced age, particularly in postmenopausal women (55) , it has been associated with hyponatremia (56), and almost 50% of reports of chronic hyponatremia are due to inappropriately elevated secretion of vasopressin (1, 57) . Thus, recognizing the causal chain by which aging results in inappropriately increased vasopressin secretion may lead to new targets for preventing osteoporosis.
